International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company (GEMA)

Overview

The International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock Company is a specialized entity that offers biobanking services, chiefly focusing on the preservation of cord blood stem cells and umbilical cord tissue. Established in the year 2003, and having its foundation rooted in Moscow, Russia, this organization stands as a pivotal pioneer in the region for stem cell banking. Operating principally within Russia and the Commonwealth of Independent States (CIS), the company caters to a wide demographic, ensuring the availability of cutting-edge biological storage services. As a strategic business unit under the umbrella of the Human Stem Cells Institute PJSC, the International Medical Center of Biomaterials Processing and Cryostorage emphasizes innovation and excellence in the burgeoning field of biotechnology, specifically in the domain of cryostorage and biomaterials processing. This association underlines its significant role and contribution to the biosciences sector, not only as a commercial entity but also as a beacon of progress in the medical science community.

Products and Services

• Cord Blood Stem Cells Banking

Offering a secure and reliable service for the collection, processing, and long-term cryopreservation of stem cells derived from umbilical cord blood. This service is pivotal for future therapeutic uses, including the treatment of a variety of genetic, hematologic, and immunologic disorders. It provides families with a form of biological insurance, potentially offering lifesaving treatment options for conditions that currently have limited treatment modalities.

• Umbilical Cord Tissue Storage

This service focuses on the preservation of umbilical cord tissue, which is a rich source of Mesenchymal Stem Cells (MSCs). MSCs are widely researched for their regenerative properties and potential therapeutic applications in regenerative medicine, including tissue repair and the treatment of inflmmatory and autoimmune diseases. By banking umbilical cord tissue, parents are safeguarding access to a wider range of cells that might be used in future medical treatments.